SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Shree Ganesh Remedies

BSE: 540737 29 Jun 2025
Healthcare
₹ 601.25
Shree Ganesh Remedies Limited specializes in Pharmaceuticals within the Healthcare sector.

Shree Ganesh Remedies - Share Price & Details

Market Cap
₹772.0
High /Low
950.0 / 592.0
Stock P/E
33.5
Book Value
₹113.0
Dividend Yield
0.0
ROCE
19.5
ROE
₹17.3
Face Value
10.0
PEG Ratio
1.96
EVEBITDA
₹18.6
Debt
38.4
CMP / FCF
NA
Debt to equity
₹0.26
NP Ann
23.1
High price all time
950.0
Piotroski score
₹6.0
Graham Number
214.0
No. Eq. Shares
1.28
Net CF
₹-6.08
Net profit
23.1
Price to book value
5.32
Interest Coverage
₹15.8
Low price all time
22.1
Industry PE
32.7
Reserves
₹132
Free Cash Flow
₹7.48

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
Shree Ganesh Remedies LimitedNANANANA772.033.5
KILITCH DRUGS (INDIA) LTD.586.29113.74563.047.0769427.8
IND-SWIFT LABORATORIES LTD.NANANANA6658.04

Peer Comparison Chart


About Shree Ganesh Remedies

Shree Ganesh Remedies Limited, with Security Code 540737, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Has Shree Ganesh Rem declared dividend?

(07 Jun 2025)
Shree Ganesh Remedies Ltd has declared a 5% dividend, amounting to 0.5 per share, with an ex-date of September 7, 2023.
Read more →

Music Broadcast Ltd leads losers in 'B' group

(23 May 2025)
Mumbai, May 21 -- Shree Ganesh Remedies Ltd, Themis Medicare Ltd, JHS Svendgaard Retail Ventures Ltd and Gulshan Polyols Ltd are among the other losers in...
Read more →

Ganesh Benzoplast Ltd leads losers in 'B' group

(22 May 2025)
Mumbai, May 20 -- Baid Finserv Ltd, Hindprakash Industries Ltd, Shree Ganesh Remedies Ltd and Pondy Oxides & Chemicals Ltd are among the other losers in the...
Read more →

Shree Ganesh Remedies Faces Financial Declines Amid Bearish Market Sentiment

(21 May 2025)
Shree Ganesh Remedies has recently experienced an evaluation adjustment reflecting significant changes in its financial and technical metrics.
Read more →

Shree Ganesh Remedies consolidated net profit declines 47.66% in the March 2025 quarter

(20 May 2025)
Sales decline 34.56% to Rs 24.43 crore. Net profit of Shree Ganesh Remedies declined 47.66% to Rs 6.59 crore in the quarter ended March 2025 as against Rs...
Read more →

Shree Ganesh Remedies Faces Valuation Shift Amid Mixed Financial Performance Indicators

(20 May 2025)
Shree Ganesh Remedies, a small-cap pharmaceutical company, has experienced a recent adjustment in its valuation grade. Despite a 21.36% return over the past...
Read more →